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PREFACE 
The thesis work delineates the rational design and successful syntheses of 
platinum(II) complexes for achieving light promoted dual action anticancer 
properties. The research work focuses on the syntheses, elaborate characterization 
including crystallization and mechanistic aspects of photodegradation processes. 
Theoretical studies were done to elucidate the properties of the excited states. The 
interaction of active Pt(II) species with DNA is also explored. The cellular studies 
include evaluation of the photo-induced cytotoxicities, mode of cell death, nature of 
reactive oxygen species (ROS), quantification of cellular Pt content and cellular and 
sub-cellular localization of the complexes.  
Chapter I provides an overview of the hallmarks of cancer and the current 
anticancer treatment modalities. It outlines the evolution of platinum based 
chemotherapeutic drugs, their mechanism of action and associated disadvantages. It 
also depicts the resurgence of metal complexes as photosensitizers for 
photoactivated chemotherapy, a selective tripartite strategy which permits light 
induced tumor destruction. Detailed literature reports of potential transition metal 
complexes showing light induced generation of ROS and controlled delivery of 
multiple drugs in tumor microenvironment are presented. The key challenges are 
the delivery and controlled activation of the clinically approved platinum(II) drugs. 
These prime objectives of the present investigation are depicted as a concluding 
segment of this introductory chapter.  
Chapter II includes the syntheses, characterization, evaluation of visible light 
induced cytotoxicity and interaction with DNA of novel ferrocenyl terpyridine 
appended platinum(II) complexes. Detailed mechanistic investigations revealed the 
important role of ferrocene in light triggered generation of reactive oxygen species. 
The effect of extensive conjugation on the photophysical properties of the 
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complexes were also rationalized from theoretical calculations. The alteration in 
DNA binding affinities of the complexes on incorporation of a ferrocene unit in the 
platinum(II)terpyridines is also reflected. The work is the first report of the 
remarkable photocytotoxicity of platinum(II) complexes in visible light with 
nominal dark toxicity. 
Chapter III deals with novel ferrocenyl terpyridyl platinum(II) complexes 
having tumor targeting biotinylated acetylides which were synthesized for 
achieving selective photocytotoxicity only in cancer cells. An interesting observation 
was the red light promoted release of biotinylated acetylide ligands from platinum 
centre thereby generating mono-functional Pt(II) species. The possible covalent 
interactions of these platinum(II) species with DNA were also explored. These biotin 
complexes exhibit preferential cellular uptake in BT474 breast cancer cells over 
HBL-100 breast normal cells resulting in targeted photocytotoxicity in visible light. 
Chapter IV rationalizes design, syntheses and extensive characterization of 2-
(phenylazo)pyridine based platinum(II) catecholates containing photosensitizers. 
The O^O donor ligand was chosen to release the more cytotoxic bi-functional 
platinum(II) species based on the prior knowledge of the labile Pt-O bonds. 
Interestingly, we observed glutathione triggered release of the catecholates 
imparting dual action anticancer properties to the molecules. Detailed mechanistic 
aspects indicated a possible reduction of the metal coordinated azo bond by cellular 
glutathione. The excellent photocytotoxicity in HaCaT and MCF-7 cells, cellular ROS 
generation and apoptosis, cellular Pt content and localization of these complexes are 
discussed. 
Chapter V addresses the advantages of navigating the platinum(II) 
complexes to mitochondrial DNA instead of genomic DNA. BODIPY appended 
platinum(II) catecholates were synthesized and the BODIPY core was modified to 
fine-tune the photophysical properties. The visible light induced growth inhibitory 
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effects of the complexes and the mechanism of cell death in light exposed cells are 
explored. The novelty of this work is the mitochondria targeted remarkable 
photocytotoxicity as well as cellular imaging properties of the complexes making 
them ideal candidates for developing platinum based theranostic agents. 
Chapter VI presents the syntheses, characterization of unprecedented 
platinum(II) complexes of curcumin for dual action DNA crosslinking and 
photochemotherapeutic activities. The important feature of these Pt(II) prodrugs is 
the photorelease of curcumin from Pt(II) centre which results in controlled delivery 
of two potential anticancer agents. The visible light induced cytotoxicities of the 
complexes in HaCaT, BT474, T47D, Hep3B and HPL1D cells, their effect on the 
various cellular events, the interaction of the complexes with DNA and their cellular 
distribution in light and dark are explored. 
The appropriate references are provided at the end of each chapter and 
allocated as superscripts in the main text. The synthesized complexes are denoted 
by bold-faced numbers. Crystallography data of the complexes that are structurally 
characterized by single crystal X-ray crystallography are given in CIF format in the 
enclosed CD (Appendix-I). Due acknowledgements are provided for mentioned 
literature reports. Any omission is purely unintentional and is deeply regretted. 
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